| Hans-Günter Meyer-Thompson | International
USA/ASAM. The JOINT CLINICAL PRACTICE GUIDELINE ON Benzodiazepine Tapering:Considerations when Benzodiazepine Risks Outweigh Benefits
USA/ASAM. The JOINT CLINICAL PRACTICE GUIDELINE ON Benzodiazepine Tapering:Considerations when Benzodiazepine Risks Outweigh Benefits
Developed by a multidisciplinary group led by ASAM, this guideline aims to assist clinicians in helping patients safely taper from their benzodiazepine medication, while minimizing withdrawal symptoms. (ASAM, 2025)
https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/benzodiazepine-tapering-2025/bzd-tapering-document---final-approved-version-for-distribution-02-28-25.pdf